Literature DB >> 16237396

Sex differences in neurochemical effects of dopaminergic drugs in rat striatum.

Q David Walker1, Rupa Ray, Cynthia M Kuhn.   

Abstract

Previous data indicate that dopamine neurotransmission is differently regulated in male and female rats. The purpose of the present study was to investigate the dopamine transporter and autoreceptor as potential loci responsible for this sex difference. Fast cyclic voltammetry at carbon-fiber microelectrodes was used to monitor changes in electrically evoked levels of extracellular dopamine in the striata of anesthetized male and female rats before and after administration of an uptake inhibitor, a dopamine D2 antagonist, or a D3/D2 agonist. Administration of 40 mg/kg cocaine ip increased electrically-evoked extracellular dopamine concentrations in both sexes, but to a significantly greater extent in female striatum at the higher stimulation frequencies. The typical antipsychotic, haloperidol, increased dopamine efflux in both sexes but the effect was twice as large in the female striatum. The D3/D2 agonist quinpirole induced an unexpected, transient increase in dopamine efflux following high-frequency stimulation only in females, and evoked dopamine was higher in females across this entire time course. More detailed analysis of cocaine effects revealed no fundamental sex differences in the interaction of cocaine with DAT in vivo or in synaptosomes. These results indicate that nigrostriatal dopamine neurotransmission in the female rat is more tightly regulated by autoreceptor and transporter mechanisms, perhaps related by greater autoreceptor control of DAT activity. Thus, baseline sex differences in striatal dopamine regulation induce different pharmacologic responses. These results contribute to understanding sex differences in stimulant-induced locomotor activity in rats and may have broader implications for neurologic disorders and their pharmacotherapies in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16237396     DOI: 10.1038/sj.npp.1300915

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  63 in total

Review 1.  Sex differences in drug abuse.

Authors:  Jill B Becker; Ming Hu
Journal:  Front Neuroendocrinol       Date:  2007-08-24       Impact factor: 8.606

Review 2.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

Review 3.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

4.  Evaluation of sex differences in cannabinoid dependence.

Authors:  Julie A Marusich; Timothy W Lefever; Kateland R Antonazzo; Rebecca M Craft; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2014-02-12       Impact factor: 4.492

5.  Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats.

Authors:  Shayla E Russell; Anna B Rachlin; Karen L Smith; John Muschamp; Loren Berry; Zhiyang Zhao; Elena H Chartoff
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

6.  Individual differences in initial low-dose cocaine-induced locomotor activity and locomotor sensitization in adult outbred female Sprague-Dawley rats.

Authors:  Bruce H Mandt; Richard M Allen; Nancy R Zahniser
Journal:  Pharmacol Biochem Behav       Date:  2008-09-10       Impact factor: 3.533

Review 7.  The emergence of gonadal hormone influences on dopaminergic function during puberty.

Authors:  Cynthia Kuhn; Misha Johnson; Alex Thomae; Brooke Luo; Sidney A Simon; Guiying Zhou; Q David Walker
Journal:  Horm Behav       Date:  2009-11-10       Impact factor: 3.587

Review 8.  Sexual differentiation of motivation: a novel mechanism?

Authors:  Jill B Becker
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

9.  Basal and cocaine-induced sex differences in the DARPP-32-mediated signaling pathway.

Authors:  Luyi Zhou; Arbi Nazarian; Wei-Lun Sun; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

10.  Sex differences in basal and cocaine-induced alterations in PKA and CREB proteins in the nucleus accumbens.

Authors:  Arbi Nazarian; Wei-Lun Sun; Luyi Zhou; Lynne M Kemen; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.